Ventricular assist devices were first approved in 2010 by the FDA as destination therapy for heart failure patients who were not considered candidates for heart transplant surgery. A VAD acts as a pump to help the heart distribute blood throughout the body, and over the years, the evolution of the VAD has led to significant improvements that have allowed heart failure patients to live longer lives.
